Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Endometrium > FUR1502a
  • Cores:
    150
    CASES:
    75
    Core Diameter(mm):
    1
    Thickness(µm):
    5
    Row number:
    10
    Column number:
    15
    Tissue Array Type:
    FFPE
    Species:
    Human
FUR1502a
$295.00
Add To Collect

Description: Endometrium cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing FUR1502

Details: Endometrium carcinoma tissue microarray, containing 75 cases of endometrioid adenocarcinoma, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • Malignant(IIIC1)
  • Malignant(IA)
  • Malignant(IB)
  • Malignant(IIB)
  • Malignant(II)
  • Malignant(IIIA)
  • _ma
TISSUE ARRAYS
FUR1502a
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
B
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
C
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
D
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
E
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
F
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
G
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
H
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
I
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
J
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
Ute
_ma
FUR1502a
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size
A1
1 35 F Uterus Endometrioid adenocarcinoma 1 T2N0M0 II Malignant *
A2
2 57 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant *
A3
3 57 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant *
A4
4 38 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant *
A5
5 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 5*5
A6
6 47 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 9*9
A7
7 56 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 3*2.5*1.2
A8
8 53 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 6*4*4
A9
9 54 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*2*0.5
A10
10 50 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 11*10*4
A11
11 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 6*4.5*3
A12
12 53 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 9*8*8
A13
13 68 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 7*4*4
A14
14 54 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 2*1.5*1
A15
15 43 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 8*7*6
B1
16 35 F Uterus Endometrioid adenocarcinoma 1 T2N0M0 II Malignant *
B2
17 57 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant *
B3
18 57 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant *
B4
19 38 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant *
B5
20 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 5*5
B6
21 47 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 9*9
B7
22 56 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 3*2.5*1.2
B8
23 53 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 6*4*4
B9
24 54 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*2*0.5
B10
25 50 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 11*10*4
B11
26 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 6*4.5*3
B12
27 53 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 9*8*8
B13
28 68 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 7*4*4
B14
29 54 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 2*1.5*1
B15
30 43 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 8*7*6
C1
31 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*1
C2
32 50 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 4*2
C3
33 43 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2*2
C4
34 53 F Uterus Endometrioid adenocarcinoma 1 T2N0M0 II Malignant 9*9*4
C5
35 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 4*3*1.5
C6
36 33 F Uterus Endometrioid adenocarcinoma 1--2 T1bN0M0 IB Malignant 11*9*4
C7
37 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3.5
C8
38 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*4*0.5
C9
39 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
C10
40 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3.5*2*0.8
C11
41 61 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 3*2
C12
42 30 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
C13
43 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
C14
44 52 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
C15
45 58 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
D1
46 49 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2.5*1
D2
47 50 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 4*2
D3
48 43 F Uterus Endometrioid adenocarcinoma 1 T1aN0M0 IA Malignant 2*2
D4
49 53 F Uterus Endometrioid adenocarcinoma 1 T2N0M0 II Malignant 9*9*4
D5
50 37 F Uterus Endometrioid adenocarcinoma 1 T1bN0M0 IB Malignant 4*3*1.5
D6
51 33 F Uterus Endometrioid adenocarcinoma 1--2 T1bN0M0 IB Malignant 11*9*4
D7
52 56 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3.5
D8
53 50 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*4*0.5
D9
54 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
D10
55 46 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3.5*2*0.8
D11
56 61 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 3*2
D12
57 30 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
D13
58 57 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant *
D14
59 52 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
D15
60 58 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
E1
61 46 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
E2
62 74 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3*3*2
E3
63 59 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 8*3*2.5
E4
64 54 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 2.5*2*1
E5
65 56 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 6*4.5*1.5
E6
66 70 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 1.5*4.5*2
E7
67 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
E8
68 68 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 8*6*4
E9
69 54 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 9*5*3
E10
70 50 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 6*4*2.5
E11
71 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3*3
E12
72 43 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 7*3*3
E13
73 79 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 4*3*0.8
E14
74 56 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
E15
75 63 F Uterus Endometrioid adenocarcinoma 2--3 T3aN0M0 IIIA Malignant 9*3*2.5
F1
76 46 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
F2
77 74 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 3*3*2
F3
78 59 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 8*3*2.5
F4
79 54 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 2.5*2*1
F5
80 56 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 6*4.5*1.5
F6
81 70 F Uterus Endometrioid adenocarcinoma 2 T2N0M0 II Malignant 1.5*4.5*2
F7
82 52 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 4*3*2
F8
83 68 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 8*6*4
F9
84 54 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 9*5*3
F10
85 50 F Uterus Endometrioid adenocarcinoma 2 T3aN0M0 IIIA Malignant 6*4*2.5
F11
86 58 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 5*3*3
F12
87 43 F Uterus Endometrioid adenocarcinoma 2 T1bN0M0 IB Malignant 7*3*3
F13
88 79 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant 4*3*0.8
F14
89 56 F Uterus Endometrioid adenocarcinoma 2 T1aN0M0 IA Malignant *
F15
90 63 F Uterus Endometrioid adenocarcinoma 2--3 T3aN0M0 IIIA Malignant 9*3*2.5
G1
91 58 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant 10*9*7
G2
92 52 F Uterus Endometrioid adenocarcinoma 2--3 T1bN1M0 IIIC1 Malignant *
G3
93 43 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant *
G4
94 48 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant *
G5
95 43 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant *
G6
96 42 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant 3*2.5*1
G7
97 53 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant 7*6*1.3
G8
98 58 F Uterus Endometrioid adenocarcinoma 3 T3N1M0 IIIC1 Malignant 3*2
G9
99 45 F Uterus Endometrioid adenocarcinoma 3 T1bN1M0 IIIC1 Malignant *
G10
100 54 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 6*4.5*1
G11
101 54 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 6*4.5*1
G12
102 42 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3.0*1
G13
103 48 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant *
G14
104 45 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant *
G15
105 38 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 5*4*3
H1
106 58 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant 10*9*7
H2
107 52 F Uterus Endometrioid adenocarcinoma 2--3 T1bN1M0 IIIC1 Malignant *
H3
108 43 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant *
H4
109 48 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant *
H5
110 43 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant *
H6
111 42 F Uterus Endometrioid adenocarcinoma 2--3 T1aN0M0 IA Malignant 3*2.5*1
H7
112 53 F Uterus Endometrioid adenocarcinoma 2--3 T1bN0M0 IB Malignant 7*6*1.3
H8
113 58 F Uterus Endometrioid adenocarcinoma 3 T3N1M0 IIIC1 Malignant 3*2
H9
114 45 F Uterus Endometrioid adenocarcinoma 3 T1bN1M0 IIIC1 Malignant *
H10
115 54 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 6*4.5*1
H11
116 54 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 6*4.5*1
H12
117 42 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3.0*1
H13
118 48 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant *
H14
119 45 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant *
H15
120 38 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 5*4*3
I1
121 64 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 4*4
I2
122 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3*2*1
I3
123 49 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant 5*5*4
I4
124 53 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 7*6*4
I5
125 60 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 4*3*2.5
I6
126 51 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 8*4.5*4.5
I7
127 51 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 4*3
I8
128 53 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 4*2.5*1.5
I9
129 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3*1.2
I10
130 43 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3*2.5
I11
131 66 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant *
I12
132 63 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
I13
133 55 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
I14
134 52 F Uterus Endometrioid adenocarcinoma 3 T2bN0M0 IIB Malignant *
I15
135 35 F Uterus Endometrioid adenocarcinoma 3--4 T3aN0M0 IIIA Malignant *
J1
136 64 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 4*4
J2
137 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3*2*1
J3
138 49 F Uterus Endometrioid adenocarcinoma 3 T2N0M0 II Malignant 5*5*4
J4
139 53 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 7*6*4
J5
140 60 F Uterus Endometrioid adenocarcinoma 3 T1aN0M0 IA Malignant 4*3*2.5
J6
141 51 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 8*4.5*4.5
J7
142 51 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant 4*3
J8
143 53 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 4*2.5*1.5
J9
144 62 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3*1.2
J10
145 43 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant 3.5*3*2.5
J11
146 66 F Uterus Endometrioid adenocarcinoma 3 T3aN0M0 IIIA Malignant *
J12
147 63 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
J13
148 55 F Uterus Endometrioid adenocarcinoma 3 T1bN0M0 IB Malignant *
J14
149 52 F Uterus Endometrioid adenocarcinoma 3 T2bN0M0 IIB Malignant *
J15
150 35 F Uterus Endometrioid adenocarcinoma 3--4 T3aN0M0 IIIA Malignant *
_marker_
Find overlapping cases with this tissue array:
  • FUR1502a
    File Format: .xlsx
    Release Date: 2025-01-17 16:01:00
    Download
1.994746s